Speakers

Andreas Evers

Scientific Director in Antibody Discovery & Protein Engineering, Global Research & Development, Discovery Technologies

Merck Healthcare

Andreas Hougaard Laustsen-Kiel, PhD

Professor & Group Leader for Antibody Technologies

Technical University of Denmark

Andrew Kruse

Professor of Biological Chemistry and Molecular Pharmacology

Harvard University

Anja Beschnitt, PhD

Associate Director Analytical Development

BioNTech SE

Anna Wu, PhD

Chair and Professor, Department of Immunology and Theranostics

City of Hope

Aran Labrijn, PhD

Director, Antibody Research and Technologies

Genmab

Arvind Sivasubramanian, PhD

Senior Director, Computational Biology & Platform

Adimab

Dr. Aude Segaliny, PhD

VP of Research & Development

Amberstone Biosciences

Aujan Mehregan

Inside Sales Manager, BD & Sales

Nuclera

Bassil Dahiyat, PhD

President and CEO

Xencor

Benjamin Pelletier

Co-Chair

Haynes and Boone

Brandon DeKosky, Ph.D.

Associate Professor of Chemical Engineering

MIT and The Ragon Institute

Christopher Betti, PhD

Patent Lawyer

Morgan, Lewis & Bockius LLP

Clarice Mengwen Zhang

Postdoctoral Fellow

Genentech

Dr. Dan Rohrer, PhD

Chief Technology Officer

AbTherx

Dario Gutierrez, PhD

Founder and Chief Scientific Officer

Merida Biosciences

David Bramhill, PhD

Consultant

Bramhill Biological Consulting, LLC

David Shen, PhD

CEO

Propeller Bio

David Younger, Ph.D.

Co-Founder & CEO

A-Alpha Bio

Dhaya Seshasayee, PhD

Director of Antibody Discovery

Genentech

Diana Canals, PhD

Associate Scientist

Zymeworks

Dileep Pulukkunat, PhD

Senior Director of Antibody Discovery

Invenra

Dima Kozakov, PhD

Professor

Stony Brook University

Dzmitry Padhorny, PhD

Research Assistant

The University of Texas at Austin

Eric Smith

Executive Director - Bispecifics

Regeneron Pharmaceuticals

Dr. Facundo Batista, PhD

Associate Director and Scientific Director

Ragon Institute of MGH, MIT and Harvard

Frances Lee, M.D

Professor of Medicine

Emory University

Franziska Mortensen, PhD

Associate Director

Genmab

Genevieve Desjardins

Associate Director in Protein Engineering

Zymeworks Inc

Giulia De Sabbata, PhD

Director and Head of Discovery

VectorY Therapeutics

Dr Grace Mortenson

Associate Principal Scientist

Merck Research Labs

Greg Lazar, Ph.D.

Co-Founder and Chief Scientific Officer

Dualitas Therapeutics

Gregory Moore, Ph.D.

Director, Protein Engineering

Xencor

Ibo Janssens

Senior Scientist

Argenx

Dr Isabel Elliott, PhD

Postdoctoral Researcher

University of Southampton

Isabelle Pachmayr

PhD Student

Max Planck Institute of Biochemistry

James Ernst, Ph.D.

Vice President, Development Sciences; Head of Protein Sciences & Technology

Xencor

Janine Schuurman, Ph.D.

Biotech Consultant

Lust for Life Science

Dr. Jay Bhatt, PhD

Principal Scientist

Johnson & Johnson

Jean-Philippe Julien, Ph.D.

Senior Scientist, Molecular Medicine

Hospital for Sick Children Research Inst

Jerome Boyd-Kirkup

Co-Founder & CSO

Hummingbird Bioscience, Singapore

Jihwan Chun

Postdoctoral Research Fellow

Harvard University

John Desjarlais, PhD

Chief Scientific Officer

Xencor, Inc.

John Mascola

Chief Scientific Officer

ModeX Therapeutics

John Williams

Professor, Cancer Biology and Molecular Medicine

City of Hope

Jonathan Sockolosky, PhD

Co-founder and CEO

Macaw Therapeutics

Karen Silence, PhD

Head Preclinical Product Development

Argenx

Katelyn Willis

Group Leader - Cell Biology

InhibRx

Katherine Harris, PhD

Chief Development Officer

Rondo Therapeutics

Katherine Susa, PhD

Principal Investigator

UCSF

Kipp Weiskopf

Head of Antibody Therapeutics and Biologics

Beth Israel Deaconess Medical Center

Krista Kinneer

Director, Oncology Translational Medicine

AstraZeneca

Kyle Doolan, PhD

Senior Director of R&D

Integral Molecular

Marissa Mock, PhD

Executive Director of Protein Therapeutics

Amgen

Martin Steegmaier, Ph.D.

Chief Scientific Officer

Molecular Partners AG

Dr Maurits Kleijnen

Chief Technology Officer

Intract Pharma Ltd

Megan Rice

Associate Principal Scientist

AstraZeneca

Meredith Hazen

Scientist

Genentech

Mitchell Ho, PhD

Senior Investigator, Laboratory of Molecular Biology

NIH NCI

Musheng Bao, PhD

Head of Biology

Nona Biosciences

Naoka Hironiwa

Chief Scientist

Chugai Pharmaceutical co. ltd.

Nasa Savory

Senior Scientist

Chugai Pharmaceutical Co., Ltd

Natalie Galant

CEO

Paradox Immunotherapeutics

Nicholas Wu

Assistant Professor, Department of Biochemistry

University of Illinois at Urbana-Champaign

Nicole Schirle Oakdale

Principal Scientist

Gilead Sciences, Inc

Nikolai Suslov

VP, Waltham Site Lead, Antibody Division

Alloy Therapeutics

Paul Parren, PhD

Founder and CSO

Gyes BV

Peter Sondermann

CSO

Tacalyx GmbH

Peter Tessier, PhD

Albert M. Mattocks Professor, Departments of Pharmaceutical Sciences, Chemical Engineering and Biomedical Engineering

University of Michigan

Pin-Kuang Lai

Assistant Professor

Stevens Institute of Technology

Dr. Robert Chen, PhD

Antibody Engineer

Chai Discovery

Russell Coleman

Director, Strain Engineering

Primrose Bio

Dr. Ryan Henrici, M.D., Ph.D.

Senior Director, Translational Research

BigHat Biosciences

Saileta Prabhu, PhD

Clinical Pharmacologist

Regeneron

Sally Ward, PhD

Professor and Director

University of Southampton

Mr. Sam Ellis

Chief Executive Officer

Thomson Instrument Company

Samantha Hullah, PhD

Executive Director, Biologics SME.

Syngene

Sang Taek Jung, PhD

Associate Professor

Seoul National University

Sanjaya Singh, PhD

Founder and Chief Scientific Officer

Third Arc Bio

Shiva Bhowmik

President & CEO

Trio Pharmaceuticals

Simon Davis, PhD

Professor of Molecular Immunology

University of Oxford

Dr. Stefan Warmuth, PhD

SVP, Head Technology and CMC

Numab Therapeutics AG

Stephanie Casey Parks, PhD

Senior Principal Scientist

Amgen

Stephen Beers, PhD

Professor of Immunology and Immunotherapy

University of Southampton

Steven Jacobs, PhD

Senior Director of Biophysics & Molecular Attributes within Therapeutics Discovery

Johnson & Johnson Innovative Medicine

Susan Kalled, PhD

Scientific Advisory Board Member

Commit Biologics

Takashi Ebihara (Ebi), PhD

COO

GeneFrontier Corporation

Takashi Sato, PhD

Chief Scientist & Technical Architect, Life Science Product Division

Rigaku Corporation

Thomas Vincent

Senior Director of Antibody Technology

Alloy Therapeutics

Tian Zhao, PhD

Vice President of R&D

OncoNano Medicine Inc.

Udaya Rangaswamy, Ph.D.

Senior Scientist

Rondo therapeutics

Vaishali Kapoor

Assistant Professor, Radiation Oncology

Washington University School of Medicine

Vibha Jawa

Chief Scientific Officer

EpiVax, Inc

Dr Xiuling Li

Director

AstraZeneca

Yi Shi, Ph.D.

Professor

University of Pittsburgh, School of Medicine

Yuejiao Xian, PhD

Principal Investigator

Incyte

Dr. Yunxuan Xie, PhD

Graduate Research Assistant

University of Michigan